These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 19908625)

  • 1. [Virulence blocking antibiotics. Anti-bacterial agents with completely new action mechanisms].
    Sundin C; Elofsson M; Wolf-Watz H; Rosell S
    Lakartidningen; 2009 Sep 30-Oct 6; 106(40):2543-5. PubMed ID: 19908625
    [No Abstract]   [Full Text] [Related]  

  • 2. Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram-negative bacteria.
    Keyser P; Elofsson M; Rosell S; Wolf-Watz H
    J Intern Med; 2008 Jul; 264(1):17-29. PubMed ID: 18393958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial resistance, beta-lactam antibiotics and gramnegative bacteria at ICUs.
    Reisinger EC; Allerberger F
    Wien Klin Wochenschr; 1999 Jul; 111(14):537-8. PubMed ID: 10467639
    [No Abstract]   [Full Text] [Related]  

  • 4. Importance of antibiotic resistance and resistance mechanisms. Foreword.
    Bonomo RA; Rossolini GM
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):549-50. PubMed ID: 18847392
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanisms of resistance to beta-lactams in some common Gram-negative bacteria causing nosocomial infections.
    Suárez CJ; Lolans K; Villegas MV; Quinn JP
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):915-22. PubMed ID: 16307504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Septicemia with gram-negative bacilli. The possibilities and limits of an etiological therapy].
    Grigore L
    Bacteriol Virusol Parazitol Epidemiol; 1996; 41(3-4):151-60. PubMed ID: 9116405
    [No Abstract]   [Full Text] [Related]  

  • 7. What is in the pipeline for Gram-negative pathogens?
    Talbot GH
    Expert Rev Anti Infect Ther; 2008 Feb; 6(1):39-49. PubMed ID: 18251663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combating evolution with intelligent design: the neoglycoside ACHN-490.
    Armstrong ES; Miller GH
    Curr Opin Microbiol; 2010 Oct; 13(5):565-73. PubMed ID: 20932796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular insights into aminoglycoside action and resistance.
    Magnet S; Blanchard JS
    Chem Rev; 2005 Feb; 105(2):477-98. PubMed ID: 15700953
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimising outcomes of hospital infections through appropriate empirical antimicrobial therapy. Introduction.
    Lode H
    Clin Microbiol Infect; 2008 Apr; 14 Suppl 3():1-2. PubMed ID: 18318873
    [No Abstract]   [Full Text] [Related]  

  • 11. Intra-abdominal infections: do we need to change our antibiotic coverage in this era of Gram negative resistance?
    Gopalakrishnan R
    J Assoc Physicians India; 2011 May; 59():285. PubMed ID: 21751603
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel immunotherapeutic approaches to the treatment of infections caused by Gram-negative bacteria.
    Palliyil S; Broadbent ID
    Curr Opin Pharmacol; 2009 Oct; 9(5):566-70. PubMed ID: 19726227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug-resistant Gram-negative bacteria in postoperative infections.
    Singh AV; Mishra B; Thakur A
    J Indian Med Assoc; 2009 Mar; 107(3):148-50, 163. PubMed ID: 19810380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New plasmid-mediated resistances to antimicrobial agents.
    Courvalin P
    Arch Microbiol; 2008 Apr; 189(4):289-91. PubMed ID: 18094959
    [No Abstract]   [Full Text] [Related]  

  • 15. Multidrug resistant gram-negative bacteria in clinical isolates from Karachi.
    Saeed A; Khatoon H; Ansari FA
    Pak J Pharm Sci; 2009 Jan; 22(1):44-8. PubMed ID: 19168419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New antibiotics for severe sepsis--the break-through?].
    Burgmann H
    Dtsch Med Wochenschr; 2008 Feb; 133(8):372-3. PubMed ID: 18270921
    [No Abstract]   [Full Text] [Related]  

  • 17. Emerging Gram-negative antibiotic resistance: daunting challenges, declining sensitivities, and dire consequences.
    Arya SC; Agarwal N; Agarwal S
    Respir Care; 2008 Dec; 53(12):1749-50; author reply 1750. PubMed ID: 19025713
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of colistin in children.
    Tamma PD; Lee CK
    Pediatr Infect Dis J; 2009 Jun; 28(6):534-5. PubMed ID: 19483519
    [No Abstract]   [Full Text] [Related]  

  • 19. Emergence of polymyxin resistance in Gram-negative bacteria.
    Olaitan AO; Li J
    Int J Antimicrob Agents; 2016 Dec; 48(6):581-582. PubMed ID: 27939183
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization and anti-microbial susceptibility of gram-negative bacteria isolated from bloodstream infections of cancer patients on chemotherapy in Pakistan.
    Saghir S; Faiz M; Saleem M; Younus A; Aziz H
    Indian J Med Microbiol; 2009; 27(4):341-7. PubMed ID: 19736404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.